Verastem Oncology to Announce Third Quarter 2019 Financial Results and Corporate Update on October 29, 2019
October 17 2019 - 7:00AM
Business Wire
Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company),
a biopharmaceutical company focused on developing and
commercializing medicines seeking to improve the survival and
quality of life of cancer patients, today announced that the
Company will host a conference call and webcast on Tuesday, October
29, 2019 at 4:30 p.m. Eastern Time to discuss corporate updates and
financial results for the third quarter ended September 30,
2019.
The call can be accessed by dialing (877) 341-5660 (U.S. and
Canada) or (315) 625-3226 (international), five minutes prior to
the start of the call and providing the passcode 5785818. The live,
listen-only webcast of the conference call can be accessed by
visiting the investors section of the Company's website at
www.verastem.com. A replay of the webcast will be archived on the
Company's website for 90 days following the call.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a commercial
biopharmaceutical company committed to the development and
commercialization of medicines to improve the lives of patients
diagnosed with cancer. We are driven by the strength, tenacity and
courage of those battling cancer – single-minded in our resolve to
deliver new therapies that not only keep cancer at bay but improve
the lives of patients diagnosed with cancer. Because for us, it’s
personal.
Our first FDA approved product is now available for the
treatment of patients with certain types of indolent non-Hodgkin’s
lymphoma (iNHL). Our pipeline comprises product candidates that
seek to treat cancer by modulating the local tumor
microenvironment. For more information, please visit
www.verastem.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191017005070/en/
Investors: John Doyle Vice President, Investor Relations &
Finance +1 781-469-1546 jdoyle@verastem.com
Media: Lisa Buffington Corporate Communications +1 781-292-4205
lbuffington@verastem.com
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Sep 2023 to Sep 2024